Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease. 2021

Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
BioArctic AB, Warfvinges väg 35, SE-112 51 Stockholm, Sweden.

Down syndrome (DS) is caused by trisomy of chromosome 21, which leads to a propensity to develop amyloid β (Aβ) brain pathology in early adulthood followed later by cognitive and behavioral deterioration. Characterization of the Aβ pathology is important to better understand the clinical deterioration of DS individuals and to identify interventive strategies. Brain samples from people with DS and Alzheimer's disease (AD), as well as non-demented controls (NDC), were analyzed with respect to different Aβ species. Immunohistochemical staining using antibodies towards Aβ was also performed. Elevated levels of soluble Aβ protofibrils and insoluble Aβx-40 and Aβx-42 in formic acid brain extracts, and elevated immunohistochemical staining of Aβ deposits were demonstrated with the antibody BAN2401 (lecanemab) in DS and AD compared with NDC. These data and the promising data in a large phase 2 CE clinical trial with lecanemab suggest that lecanemab may have the potential to preserve cognitive capacity in DS. Lecanemab is currently in a phase 3 CE clinical trial.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid

Related Publications

Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
January 1992, Progress in clinical and biological research,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
December 2010, Proteins,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
March 1987, Science (New York, N.Y.),
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
May 2010, PloS one,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
February 2007, The FEBS journal,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
January 2016, Frontiers in aging neuroscience,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
February 2010, International journal of geriatric psychiatry,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
September 2023, Proceedings of the National Academy of Sciences of the United States of America,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
June 1997, FEBS letters,
Malin Johannesson, and Charlotte Sahlin, and Linda Söderberg, and Hans Basun, and Johanna Fälting, and Christer Möller, and Olof Zachrisson, and Dan Sunnemark, and Anne Svensson, and Tomas Odergren, and Lars Lannfelt
October 2011, FEBS letters,
Copied contents to your clipboard!